LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 228 filers reported holding LOXO ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,526,000 | -17.2% | 10,900 | +0.9% | 0.01% | 0.0% |
Q3 2018 | $1,844,000 | +5.3% | 10,800 | +6.9% | 0.01% | 0.0% |
Q2 2018 | $1,752,000 | +746.4% | 10,100 | +461.1% | 0.01% | +700.0% |
Q1 2018 | $207,000 | +146.4% | 1,800 | +80.0% | 0.00% | – |
Q4 2017 | $84,000 | -63.5% | 1,000 | -60.0% | 0.00% | -100.0% |
Q3 2017 | $230,000 | +15.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $200,000 | -83.5% | 2,500 | -91.3% | 0.00% | -80.0% |
Q1 2017 | $1,211,000 | +9.1% | 28,783 | -16.7% | 0.01% | 0.0% |
Q4 2016 | $1,110,000 | +224.6% | 34,566 | +164.1% | 0.01% | +150.0% |
Q3 2016 | $342,000 | +32.0% | 13,089 | +16.9% | 0.00% | +100.0% |
Q2 2016 | $259,000 | -7.8% | 11,200 | +8.7% | 0.00% | 0.0% |
Q1 2016 | $281,000 | -4.1% | 10,300 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $293,000 | +1992.9% | 10,300 | +758.3% | 0.00% | – |
Q1 2015 | $14,000 | 0.0% | 1,200 | 0.0% | 0.00% | – |
Q4 2014 | $14,000 | -56.2% | 1,200 | -50.0% | 0.00% | – |
Q3 2014 | $32,000 | – | 2,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 3,438,920 | $289,488,000 | 57.19% |
DAFNA Capital Management LLC | 296,000 | $24,917,000 | 13.42% |
Casdin Capital, LLC | 360,000 | $30,305,000 | 7.38% |
Opaleye Management Inc. | 176,300 | $14,841,000 | 4.75% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 574,495 | $48,361,000 | 1.84% |
SECTORAL ASSET MANAGEMENT INC | 152,185 | $12,811,000 | 1.60% |
AWM Investment Company, Inc. | 85,000 | $7,155,000 | 1.39% |
Eventide Asset Management | 285,000 | $23,991,000 | 1.25% |
Rock Springs Capital Management LP | 310,000 | $26,096,000 | 1.18% |
Crawford Lake Capital Management, LLC | 53,420 | $4,497,000 | 1.06% |